BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02315 BIOCYTOGEN-B

Market Closed 01-09 16:08:33

35.900

+0.940

+2.69%

High36.660	Low34.200	Vol1.82M
Open35.380	D1 Closing34.960	Amplitude7.04%
Mkt Cap16.05B	Tradable Cap3.98B	Total Shares447.00M
T/O64.88M	T/O Rate1.64%	Tradable Shares111.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"BIOCYTOGEN-B","latestPrice":35.9,"timestamp":1767946113476,"preClose":34.96,"halted":0,"volume":1818946,"delay":0,"floatShares":111000000,"shares":447000000,"eps":0.084274,"marketStatus":"Market Closed","change":0.94,"latestTime":"01-09 16:08:33","open":35.38,"high":36.66,"low":34.2,"amount":64878256,"amplitude":0.070366,"askPrice":36,"askSize":3500,"bidPrice":35.9,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.324,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":7,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":34.96,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":1.0430891771406723,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"Biocytogen Pharmaceuticals (Beijing) Co.,Ltd.","latestPrice":59.79,"timestamp":1767942000000,"preClose":56.17,"halted":0,"volume":5036600,"delay":0,"premium":"-46.26"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"1168296949","title":"ZhTong Hong Kong Stock Connect Shareholding Ratio Changes Statistics | January 9th","url":"https://stock-news.laohu8.com/highlight/detail?id=1168296949","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168296949?lang=en_us&edition=fundamental","pubTime":"2026-01-09 08:39","pubTimestamp":1767919149,"startTime":"0","endTime":"0","summary":"According to disclosed data as of December 31, 2025, Goldwind Tech (02208), Novosense (02676), and Synagistics Holdings (02562) recorded the largest increases in their Hong Kong Stock Connect...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359202008.SGD","LU0531971595.HKD","BK1526","BK1558","BK1516","BK1144","LU1046422090.SGD","LU2045819591.USD","06963","LU0164939612.USD","01375","BK1587","BK1189","LU0307460666.USD","BK1535","BK1565","BK1184","HK0000165453.HKD","02579","LU0620787316.HKD","02628","BK1095","BK1205","LU0488056044.USD","01057","BK1169","03069","LU0359201885.HKD","LU1282649067.USD","01357","BK1612","02432","02603","09666","IE0032431581.USD","BK1501","BK1544","BK1129","02050","BK1170","SG9999001093.SGD","BK1609","BK1221","BK1594","BK1607","LU0039217434.USD","BK1258","BK1550","IE00BMQBXF63.USD","LU0414403682.SGD","SG9999012736.USD","02192","LU2097828474.EUR","LU0588546209.SGD","SG9999003461.SGD","06166","LU0359201612.USD","BK1141","06178","BK1185","LU2097828631.EUR","03958","01772","BK1521","BK1229","03908","00177","LU1282649810.SGD","LU1211504680.USD","BK1190","LU0082770016.USD","BK1166","LU2125910500.SGD","BK1555","LU0082770016.SGD","01138","06881","06613","BK1513","BK1610","BK1161","01788","BK1149","SG9999014674.SGD","IE00BZ18W456.USD","BK1506","LU0049112450.USD","00763","SG9999012728.SGD","BK1109","06066","00553","SG9999012744.USD","SG9999002950.SGD","02562","BK1546","LU0384037296.USD","BK1509","BK1171","SGXZ90724238.SGD","BK1618","LU0173614495.USD","BK1554","01528","BK1138","03347","BK1523","BK1564","01618","06099","LU2125910849.SGD","06693","BK1542","SG9999001069.SGD","BK1584","02865","BK1613","01635","02800","LU0164865239.USD","02431","SG9999001051.SGD","LU2097828805.USD","BK1198","BK1240","SG9999006597.SGD","LU1023057109.AUD","LU2097828714.EUR","01709","03759","BK1576","BK1237","BK1592","02648","LU2097828557.USD","BK1116","03678","LU0871576103.HKD","LU0738912210.USD","01858","BK1137","BK1183","BK1583","02402","SG9999012710.SGD","03423","BK1585","BK1163","06869","02676","01341","01456","BK1529","LU0211977185.USD","SG9999002828.SGD","BK1148","00699","00187","LU1235295612.USD","BK1567","IE00BZ18W340.USD","BK1147","01918","03441","02315","LU0287142896.SGD","02208","06865","BK1100","06680","02172"],"gpt_icon":1},{"id":"1174153906","title":"GLMS Securities Initiates Coverage on Biocytogen (02315) with \"Recommend\" Rating, Citing Stable Growth in Core Business and High Flexibility in Antibody Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1174153906","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174153906?lang=en_us&edition=fundamental","pubTime":"2026-01-05 10:46","pubTimestamp":1767581200,"startTime":"0","endTime":"0","summary":"GLMS Securities has published a research report initiating coverage on Biocytogen (02315) with a \"Recommend\" rating, noting that the company's three major business segments are thriving in a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01456","BK0276","BK1564","688796","BK0216","161027","601456","BK1147","02315"],"gpt_icon":0},{"id":"1137433724","title":"BIOCYTOGEN-B Surges Over 5% Intraday; Huafu Securities Initiates \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1137433724","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137433724?lang=en_us&edition=fundamental","pubTime":"2025-12-31 10:20","pubTimestamp":1767147636,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 5% during the trading session. As of the time of writing, the stock was up 3.26%, currently trading at HKD 35.50, with a turnover of HKD 31.2655 million. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","BK1161","161027","688796","02315"],"gpt_icon":0},{"id":"1132183254","title":"BIOCYTOGEN-B (02315) Rises Over 5% Again, Recently Added to Stock Connect List, Institutions Say \"Thousand Mice Ten Thousand Antibodies\" Strategy Begins Paying Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1132183254","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132183254?lang=en_us&edition=fundamental","pubTime":"2025-12-31 10:10","pubTimestamp":1767147021,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) surged more than 5% again. As of the time of writing, the stock was up 4.94% to HK$36.08, with a turnover of HK$27.5841 million. On the news front, the Shanghai Stock Exchange...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","02315","688796","BK1161"],"gpt_icon":0},{"id":"1198414398","title":"BIOCYTOGEN-B (02315) Surges Over 6% to Hit New Record High After Inclusion in Hong Kong Stock Connect, Institutions Highlight Vast Potential of \"10,000-Antibody\" Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=1198414398","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198414398?lang=en_us&edition=fundamental","pubTime":"2025-12-29 09:58","pubTimestamp":1766973507,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 6% during the morning session, reaching a high of HK$37.28 and setting a new record high since its listing. As of the writing of this report, the stock was up...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688796","02315","BK1161"],"gpt_icon":0},{"id":"1189874420","title":"Stock Track | BIOCYTOGEN-B Soars 5.19% Intraday on Hong Kong Stock Connect Inclusion and Strong Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1189874420","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189874420?lang=en_us&edition=fundamental","pubTime":"2025-12-29 09:36","pubTimestamp":1766972210,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) saw its stock price surge 5.19% during Monday's intraday trading session, driven by its recent inclusion in the Hong Kong Stock Connect list and robust earnings performance.The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02315"],"gpt_icon":0},{"id":"1175326877","title":"BIOCYTOGEN-B (02315) Added to Hong Kong Stock Connect List; Strong Earnings Growth Drives Value Reassessment","url":"https://stock-news.laohu8.com/highlight/detail?id=1175326877","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175326877?lang=en_us&edition=fundamental","pubTime":"2025-12-29 09:00","pubTimestamp":1766970049,"startTime":"0","endTime":"0","summary":"Recently, the Shanghai and Shenzhen Stock Exchanges announced that BIOCYTOGEN-B (02315) will be included in the Hong Kong Stock Connect list, effective from December 24, 2025. This move marks another...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688796","BK0216","02315"],"gpt_icon":0},{"id":"2595277463","title":"Asian Growth Companies With Strong Insider Ownership December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2595277463","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595277463?lang=en_us&edition=fundamental","pubTime":"2025-12-29 06:07","pubTimestamp":1766959679,"startTime":"0","endTime":"0","summary":"As the Asian markets continue to navigate a complex economic landscape, characterized by mixed growth signals and cautious optimism, investors are increasingly looking towards companies with robust insider ownership as potential opportunities. In this context, stocks with strong insider involvement often indicate confidence in the company's future prospects and alignment of interests between management and shareholders, making them appealing for those seeking growth in uncertain times.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2097/mixue-group-shares/news/asian-growth-companies-with-strong-insider-ownership-decembe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2097/mixue-group-shares/news/asian-growth-companies-with-strong-insider-ownership-decembe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"1161480720","title":"Semiconductor Price Hikes Fuel AI Material Stocks; Nickel Resources Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1161480720","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161480720?lang=en_us&edition=fundamental","pubTime":"2025-12-24 20:08","pubTimestamp":1766578101,"startTime":"0","endTime":"0","summary":"**Market Overview**   On Christmas Eve, Hong Kong stocks traded for only half a day, closing up 0.17% amid cautious sentiment ahead of the holiday break. Meanwhile, A-shares remained resilient. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f57bebb45a52df12048ae0f9d1c62763","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1237","BK1179","BK1551","BK4213","BK1553","BK1526","BK1149","03833","BK1240","BK1607","BK1161","VIS","002703","02315","02432","00826","03858","BK1170","BK1587","02498","02579","BK0264","BK1610","00981","BK1163","688796","BK1223","BK1225","09858","GDP","01812","02689","BK4585","BK1183","SG9999014674.SGD","BK1190","BK1212","06166","BK4588","02245","BK1116","BK1514","01057","01117","BK0216","BK1614","BK0132","00148","02314","BK1144"],"gpt_icon":1},{"id":"1172649176","title":"Hong Kong Stocks See Narrow Fluctuations in Half-Day Trading; Semiconductors and Nuclear Power Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=1172649176","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172649176?lang=en_us&edition=fundamental","pubTime":"2025-12-24 14:06","pubTimestamp":1766556382,"startTime":"0","endTime":"0","summary":"On December 24, Hong Kong stocks traded for only half a day due to the holiday season, closing after the morning session. The market showed narrow fluctuations with notable sector divergence, as...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HTImain","02302","01164","SOXX","00981","02315","02878","688981","BK4585","BK4588","HSI","SMH","01811","HSTECH"],"gpt_icon":0},{"id":"2593429319","title":"Biocytogen Pharmaceuticals H Shares Added to Hong Kong, Shenzhen Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2593429319","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593429319?lang=en_us&edition=fundamental","pubTime":"2025-12-24 13:08","pubTimestamp":1766552926,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals   said its H shares were added to the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect programs, according to a Hong Kong bourse filing Wednesday.The inclusion will allow investors in mainland China to directly deal in the H shares of the firm listed in Hong Kong.Biocytogen Pharmaceuticals also recently made its debut on the Shanghai Stock Exchange.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"1128280146","title":"BIOCYTOGEN-B (02315) Surges Over 5% Intraday After Successful STAR Market Listing, Establishing Dual A+H Listing Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1128280146","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128280146?lang=en_us&edition=fundamental","pubTime":"2025-12-12 15:46","pubTimestamp":1765525618,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 5% during intraday trading, settling at a 4.15% gain to HK$28.12 by press time, with a turnover of HK$19.51 million. The company made its debut on the Shanghai...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","688796","02315","BK1161"],"gpt_icon":0},{"id":"1142693244","title":"BIOCYTOGEN-B (02315) Issues 47.5 Million A Shares on December 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1142693244","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142693244?lang=en_us&edition=fundamental","pubTime":"2025-12-10 20:28","pubTimestamp":1765369717,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) announced the issuance of 47.5 million A shares on December 10, 2025. Additionally, the company converted 288.6 million non-listed shares into 288.6 million A shares.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","159982","BK1161","399300","688796"],"gpt_icon":0},{"id":"2590758457","title":"Biocytogen Pharmaceuticals Files Next Day Disclosure Return to HKEX for 47.5 Million New Shares at RMB 26.68 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2590758457","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590758457?lang=en_us&edition=fundamental","pubTime":"2025-12-10 20:16","pubTimestamp":1765369016,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals Beijing Co. Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, announcing the issuance of 47,500,000 new A shares at an issue price of RMB 26.68 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biocytogen Pharmaceuticals Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDLbQcwgx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688796","02315","BK1161"],"gpt_icon":0},{"id":"1117351114","title":"BIOCYTOGEN-B Completes A-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1117351114","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117351114?lang=en_us&edition=fundamental","pubTime":"2025-12-10 08:50","pubTimestamp":1765327823,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) announced the completion of its A-share issuance. The company's A-shares will commence trading on the Shanghai Stock Exchange's STAR Market on December 10, 2025. The Board of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","399300","02315","BK1161","688796"],"gpt_icon":0},{"id":"2590327180","title":"Biocytogen Pharmaceuticals Files Director List to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2590327180","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590327180?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:46","pubTimestamp":1765320371,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals  Co., Ltd. has filed its list of directors and their roles with the Hong Kong Stock Exchange. The Board includes Dr. Shen Yuelei, serving as Chairman, CEO, and General Manager, alongside Dr. Ni Jian as Executive Director. Non-executive Directors are Mr. Wei Yiliang, Dr. Zhou Kexiang, and Ms. Zhang Leidi. The Board also features Independent Non-executive Directors Mr. Hua Fengmao, Dr. Yu Changyuan, and Ms. Liang Xiaoyan, as well as Employee Director Ms. Li Yan. Committee memberships were also detailed: Dr. Shen Yuelei chairs the Strategy Development Committee and is a member of the Nomination Committee; Dr. Ni Jian is a member of the Remuneration and Evaluation Committee; Mr. Wei Yiliang sits on the Audit and Strategy Development Committees; Dr. Zhou Kexiang and Ms. Zhang Leidi are members of the Strategy Development Committee. Mr. Hua Fengmao chairs the Remuneration and Evaluation Committee and is a member of the Audit and Nomination Committees. Dr. Yu Changy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL3lYrT1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688796","02315"],"gpt_icon":0},{"id":"1195935013","title":"HK Stock Movement | BIOCYTOGEN-B (02315) Surges Over 12% to Record High, Set to List on STAR Market with Antibody Platform Delivering Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1195935013","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195935013?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:53","pubTimestamp":1765248807,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) surged more than 12%, reaching a record high of HK$35.86. At press time, the stock was up 12.52% at HK$35.76, with a turnover of HK$116.96 million. The rally follows the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","159982","BK1161","399300","688796"],"gpt_icon":0},{"id":"1129289078","title":"BIOCYTOGEN-B to List on Shanghai Stock Exchange STAR Market on December 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1129289078","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129289078?lang=en_us&edition=fundamental","pubTime":"2025-12-09 08:40","pubTimestamp":1765240822,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) announced that its subsidiary, Biocytogen Pharmaceuticals (Beijing) Co., Ltd., has received approval from the Shanghai Stock Exchange for the listing of its RMB-denominated...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688796","159982","02315","BK1161"],"gpt_icon":0},{"id":"1125726793","title":"HK Stock Movement | BIOCYTOGEN-B (02315) Rises Over 3% as IDEAYA's Bispecific ADC Project IDE034 Receives FDA IND Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1125726793","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125726793?lang=en_us&edition=fundamental","pubTime":"2025-12-05 14:56","pubTimestamp":1764917776,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) surged more than 3%, reaching HK$31.86 by the time of writing, with a trading volume of HK$12.99 million. The company announced that its partner IDEAYA Biosciences, Inc. (Nasdaq:...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","IND","02315","BK1161","688796","ADC"],"gpt_icon":0},{"id":"2589476854","title":"Biocytogen Pharmaceuticals Says US FDA Approves IDE034 for Human Trials; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589476854","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589476854?lang=en_us&edition=fundamental","pubTime":"2025-12-05 10:09","pubTimestamp":1764900558,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals   said its partner Ideaya Biosciences received U.S. regulatory approval to begin human trials of IDE034, according to a Hong Kong bourse filing Friday.Shares of the company gained over 3% in Friday's morning trade.The medicine was developed using Biocytogen technology and a phase 1 trial of the drug is due to begin patient enrollment in the first quarter of 2026, the firm said.The companies will initially study the drug in certain types of solid tumors.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02315","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":0.0334},{"period":"1month","weight":0.2295},{"period":"3month","weight":0.4314},{"period":"6month","weight":0.6974},{"period":"1year","weight":3.8123},{"period":"ytd","weight":0.017}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Biocytogen Pharmaceuticals (Beijing) Co Ltd is a China-based company primarily engaged in the provision of innovative animal models and pre-clinical pharmaceutical research and development services based on its independently developed gene-editing technology. The Company utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The Company is also engaged in the provision of gene-editing services. The Company operates its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.075218},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052338},{"month":3,"riseRate":0.333333,"avgChangeRate":0.185414},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.066586},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14952},{"month":6,"riseRate":0.333333,"avgChangeRate":0.011218},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"BIOCYTOGEN-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BIOCYTOGEN-B,02315,BIOCYTOGEN-B股票,BIOCYTOGEN-B股票老虎,BIOCYTOGEN-B股票老虎国际,BIOCYTOGEN-B行情,BIOCYTOGEN-B股票行情,BIOCYTOGEN-B股价,BIOCYTOGEN-B股市,BIOCYTOGEN-B股票价格,BIOCYTOGEN-B股票交易,BIOCYTOGEN-B股票购买,BIOCYTOGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}